Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The H-Ras protein is a small GTPase encoded by the HRAS gene, acting as a molecular switch in signal transduction pathways. It plays a crucial role in regulating cell division, differentiation, and survival. Mutations in HRAS can lead to oncogenic signaling, contributing to cancer development. H-Ras is part of the Ras superfamily, which includes other oncogenes like KRAS and NRAS. It is involved in the MAPK/ERK pathway and interacts with various effectors to modulate cellular processes. Despite its importance in cancer, targeting H-Ras remains challenging due to its complex signaling mechanisms.
Inhibition of GTP binding or enhancement of GTPase activity to prevent oncogenic signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H-Ras protein (H-Ras).